Product Information
RIVASTIGMINE 4.5 MG CAPSULE is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $0.2058 per EA under NDC 62332006560. Its NADAC has been published 203 times since Aug 10, 2022.
Strength
4.5 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332006560
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
RIVASTIGMINE TARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA091689On Market Since
6/12/2022
Pharmacological Classes
Price Statistics
The NADAC for RIVASTIGMINE 4.5 MG CAPSULE has been published 203 times since Aug 10, 2022, and over the history we have for it it has risen 2.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2058 per EA |
|---|---|
| All-time high | $0.3447 (Nov 16, 2022) |
| All-time low | $0.1780 (Jul 17, 2024) |
| 52-week high | $0.2215 |
| 52-week low | $0.1871 |
| Median price | $0.2139 |
| Average price | $0.2198 |
| Largest weekly change | +34.8% (Oct 19, 2022) |
| Weeks tracked | 203 |
| Tracking since | Aug 10, 2022 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of RIVASTIGMINE 4.5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for RIVASTIGMINE 4.5 MG CAPSULE, manufactured by Alembic Pharmaceuticals Inc., is $0.2058 per EA (NDC 62332006560), effective Jun 24, 2026.
How has the price of RIVASTIGMINE 4.5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for RIVASTIGMINE 4.5 MG CAPSULE has risen 2.6%. It has been tracked across 203 weekly CMS publications since Aug 10, 2022.
What are the highest and lowest recorded NADAC prices for RIVASTIGMINE 4.5 MG CAPSULE?
Since Aug 10, 2022, the NADAC for RIVASTIGMINE 4.5 MG CAPSULE has ranged from a low of $0.1780 (Jul 17, 2024) to a high of $0.3447 (Nov 16, 2022), with a median of $0.2139 per EA.
Are there cheaper alternatives to RIVASTIGMINE 4.5 MG CAPSULE?
Yes. 5 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, RIVASTIGMINE 4.5 MG CAPSULE, is $0.1992 per EA — about 3% below RIVASTIGMINE 4.5 MG CAPSULE.
Who manufactures RIVASTIGMINE 4.5 MG CAPSULE?
RIVASTIGMINE 4.5 MG CAPSULE (NDC 62332006560) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification